• Perkinelmer, Inc. Announced Revenue of $387.7 Million 
For the Fourth Quarter

News & Views

Perkinelmer, Inc. Announced Revenue of $387.7 Million For the Fourth Quarter

Feb 14 2006

PerkinElmer, Inc. announced revenue of $387.7 million for the fourth quarter ended January 1, 2006, compared to $411.6 million for the fourth quarter 2004.
Full year 2005 revenue of $1.47 billion increased 3% over 2004 driven primarily by sales growth in medical imaging and genetic screening. Due to the timing of the fiscal calendar, the fourth quarter of 2004 included an additional week. Adjusting for the impact of foreign exchange, acquisitions and an average week\'s sales in the prior fiscal period, annual revenue increased 4% over 2004. Fourth quarter 2005 revenue of $387.7 million decreased 6% over the fourth quarter of 2004. Revenue in the fourth quarter 2005, excluding the impact of foreign exchange, acquisitions and the extra week, increased 4% over the fourth quarter of the prior year.
GAAP operating profit during the fourth quarter was $49.8 million. Excluding intangibles amortisation and restructuring charges, operating profit for the fourth quarter of 2005 was $64.4 million, or approximately 16.6% of revenue, up from 14.9% in the fourth quarter of 2004. This increase in fourth quarter 2005 adjusted operating margin was due primarily to an increase in operating margins of 190 basis points in Life and Analytical Sciences and a 40 basis point increase in Optoelectronics. The company also generated operating cash flow of $83.4 million in the fourth quarter of 2005, up 17% compared to operating cash flow of $71.0 million for the fourth quarter of 2004.
\"2005 was an excellent year for PerkinElmer. We made great progress on focusing our portfolio on the Health Sciences and Photonics markets, building a very strong financial capability and strengthening our growth platforms. In addition, we delivered significant increases in operating margin and EPS,\" said Gregory L. Summe, Chairman and CEO of the Company. \"We enter 2006 with a very strong balance sheet and operating momentum. Our focus this year will be to accelerate growth through continued operational improvement and increasing our investment in innovation.\"

Digital Edition

Lab Asia 29.4 - August 2022

August 2022

In This Edition Chromatography - Automated Sample Preparation:The Missing Hyphen to Hypernation - New Low Volume Air Sampler for PFAS Analysis - Analytical Intelligence Starts with the Samp...

View all digital editions

Events

ACS National Meeting & Expo, Fall 2022

Aug 21 2022 Chicago, IL, USA & Online

ACHEMA 2022 - NEW DATES

Aug 22 2022 Frankfurt, Germany

IMSC 2022

Aug 27 2022 Maastricht, Netherlands

EuCheMS Chemistry Congress

Aug 28 2022 Lisbon, Portugal

Medical Fair Asia 2022

Aug 31 2022 Singapore

View all events